• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三碘甲状腺原氨酸与甲状腺素对三环类抗抑郁药增效作用的比较

A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants.

作者信息

Joffe R T, Singer W

机构信息

Department of Psychiatry, St. Michael's Hospital, Toronto, Ont., Canada.

出版信息

Psychiatry Res. 1990 Jun;32(3):241-51. doi: 10.1016/0165-1781(90)90029-5.

DOI:10.1016/0165-1781(90)90029-5
PMID:2201988
Abstract

Several studies suggest that small amounts of triiodothyronine (T3) will convert tricyclic antidepressant nonresponders into responders within a few days to a few weeks. As thyroxine (T4) is converted to T3 to have its physiological effect, it has been assumed that T4 would have a similar antidepressant effect to that of T3. We carried out a randomized, double-blind evaluation of the antidepressant-potentiating effect of T3 as compared with T4. Significantly more patients responded to 3 weeks of T3 as compared with T4 potentiation. Small but significant differential effects of the two thyroid hormones were noted on the Hamilton Rating Scale for Depression.

摘要

多项研究表明,少量的三碘甲状腺原氨酸(T3)能在几天到几周内将三环类抗抑郁药无反应者转变为有反应者。由于甲状腺素(T4)会转化为T3以发挥其生理作用,因此人们认为T4会具有与T3类似的抗抑郁作用。我们对T3与T4的抗抑郁增效作用进行了一项随机双盲评估。与T4增效相比,显著更多的患者对3周的T3有反应。在汉密尔顿抑郁量表上,注意到这两种甲状腺激素有微小但显著的差异效应。

相似文献

1
A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants.三碘甲状腺原氨酸与甲状腺素对三环类抗抑郁药增效作用的比较
Psychiatry Res. 1990 Jun;32(3):241-51. doi: 10.1016/0165-1781(90)90029-5.
2
Failure of T3 to potentiate tricyclic antidepressant response.三碘甲状腺原氨酸未能增强三环类抗抑郁药的反应。
J Affect Disord. 1987 Nov-Dec;13(3):267-72. doi: 10.1016/0165-0327(87)90046-2.
3
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.L-三碘甲状腺原氨酸对三环类抗抑郁药无反应者抗抑郁作用的增强
Am J Psychiatry. 1982 Jan;139(1):34-8. doi: 10.1176/ajp.139.1.34.
4
A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.在单相难治性抑郁症中,锂盐和三碘甲状腺原氨酸增强三环类抗抑郁药作用的安慰剂对照比较。
Arch Gen Psychiatry. 1993 May;50(5):387-93. doi: 10.1001/archpsyc.1993.01820170065008.
5
[Administration of thyroid hormones in therapy of psychiatric illnesses].[甲状腺激素在精神疾病治疗中的应用]
Acta Med Austriaca. 1999;26(4):129-31.
6
Influence of imipramine on the hypothalamic/pituitary/thyroid axis of the rat.丙咪嗪对大鼠下丘脑/垂体/甲状腺轴的影响。
Metabolism. 1997 Dec;46(12):1429-34. doi: 10.1016/s0026-0495(97)90143-8.
7
Normal thyroid function in desipramine nonresponders converted to responders by the addition of L-triiodothyronine.通过添加左旋三碘甲状腺原氨酸,去甲丙咪嗪无反应者转变为有反应者,甲状腺功能恢复正常。
Am J Psychiatry. 1984 Dec;141(12):1614-6. doi: 10.1176/ajp.141.12.1614.
8
Dependency of tricyclic antidepressant efficacy on thyroid hormone potentiation: case studies.三环类抗抑郁药疗效对甲状腺激素增强作用的依赖性:病例研究
J Nerv Ment Dis. 1982 Jan;170(1):50-2. doi: 10.1097/00005053-198201000-00008.
9
T3 augmentation of antidepressant treatment in T4-replaced thyroid patients.在接受甲状腺素替代治疗的甲状腺患者中,使用T3增强抗抑郁治疗效果。
J Clin Psychiatry. 1992 Jan;53(1):16-8.
10
Antidepressants and thyroid hormone levels.抗抑郁药与甲状腺激素水平。
Acta Med Austriaca. 1992;19 Suppl 1:96-7.

引用本文的文献

1
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.治疗抵抗性重度抑郁症的增强策略:系统评价和网络荟萃分析。
J Affect Disord. 2022 Apr 1;302:385-400. doi: 10.1016/j.jad.2021.12.134. Epub 2022 Jan 2.
2
The Care of Patients With Complex Mood Disorders.复杂情绪障碍患者的护理
Focus (Am Psychiatr Publ). 2020 Apr;18(2):129-138. doi: 10.1176/appi.focus.20200007. Epub 2020 Apr 23.
3
Pharmacological Treatments for Patients with Treatment-Resistant Depression.难治性抑郁症患者的药物治疗
Pharmaceuticals (Basel). 2020 Jun 4;13(6):116. doi: 10.3390/ph13060116.
4
Hormonal Treatments for Major Depressive Disorder: State of the Art.主要抑郁障碍的激素治疗:最新进展。
Am J Psychiatry. 2020 Aug 1;177(8):686-705. doi: 10.1176/appi.ajp.2020.19080848. Epub 2020 May 27.
5
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.单相抑郁的药物增效治疗:指南解读。
Int J Neuropsychopharmacol. 2020 Dec 3;23(9):587-625. doi: 10.1093/ijnp/pyaa033.
6
Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism.左甲状腺素与甲状腺干制剂治疗甲状腺功能减退症。
Thyroid. 2020 Oct;30(10):1399-1413. doi: 10.1089/thy.2020.0153. Epub 2020 May 12.
7
Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.针对主要心境障碍和精神分裂症的认知改善的激素靶向治疗:甲状腺激素和催乳素。
Clin Drug Investig. 2020 Jan;40(1):1-14. doi: 10.1007/s40261-019-00854-w.
8
Liothyronine for Depression: A Review and Guidance for Safety Monitoring.用于治疗抑郁症的三碘甲状腺原氨酸:综述与安全监测指南
Innov Clin Neurosci. 2017 Apr 1;14(3-4):24-29. eCollection 2017 Mar-Apr.
9
The Impact of Residual Symptoms in Major Depression.重度抑郁症残留症状的影响
Pharmaceuticals (Basel). 2010 Aug 3;3(8):2426-2440. doi: 10.3390/ph3082426.
10
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.甲状腺功能减退症治疗指南:由美国甲状腺协会甲状腺激素替代特别工作组制定。
Thyroid. 2014 Dec;24(12):1670-751. doi: 10.1089/thy.2014.0028.